Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct;10(10):1866-1879.
doi: 10.1016/j.apsb.2020.03.004. Epub 2020 Apr 8.

Mitochondrial quality control mechanisms as molecular targets in cardiac ischemia - reperfusion injury

Affiliations
Review

Mitochondrial quality control mechanisms as molecular targets in cardiac ischemia - reperfusion injury

Jin Wang et al. Acta Pharm Sin B. 2020 Oct.

Abstract

Mitochondrial damage is a critical contributor to cardiac ischemia/reperfusion (I/R) injury. Mitochondrial quality control (MQC) mechanisms, a series of adaptive responses that preserve mitochondrial structure and function, ensure cardiomyocyte survival and cardiac function after I/R injury. MQC includes mitochondrial fission, mitochondrial fusion, mitophagy and mitochondria-dependent cell death. The interplay among these responses is linked to pathological changes such as redox imbalance, calcium overload, energy metabolism disorder, signal transduction arrest, the mitochondrial unfolded protein response and endoplasmic reticulum stress. Excessive mitochondrial fission is an early marker of mitochondrial damage and cardiomyocyte death. Reduced mitochondrial fusion has been observed in stressed cardiomyocytes and correlates with mitochondrial dysfunction and cardiac depression. Mitophagy allows autophagosomes to selectively degrade poorly structured mitochondria, thus maintaining mitochondrial network fitness. Nevertheless, abnormal mitophagy is maladaptive and has been linked to cell death. Although mitochondria serve as the fuel source of the heart by continuously producing adenosine triphosphate, they also stimulate cardiomyocyte death by inducing apoptosis or necroptosis in the reperfused myocardium. Therefore, defects in MQC may determine the fate of cardiomyocytes. In this review, we summarize the regulatory mechanisms and pathological effects of MQC in myocardial I/R injury, highlighting potential targets for the clinical management of reperfusion.

Keywords: Apoptosis; Cardiomyocyte I/R injury; Fusion; Mitochondrial death; Mitochondrial fission; Mitochondrial quality control; Mitophagy; Necroptosis.

PubMed Disclaimer

Figures

Image 1
Graphical abstract
Figure 1
Figure 1
Overview of mitochondrial quality control (MQC) under physiological conditions and I/R injury. MQC coordinates various processes (fission, fusion, mitophagy and mitochondria-controlled cell death) to ensure cellular homeostasis. Mitochondrial dysfunction, amplified by failing quality-control processes, is believed to be a major mechanism of cardiac I/R injury. Several potential targets of MQC could be harnessed to treat cardiac I/R injury by inhibiting mitochondrial fission, promoting mitochondrial fusion, moderately activating mitophagy and inhibiting mitochondria-dependent cell death.
Figure 2
Figure 2
Mitochondrial fission is regulated by dynamin-related protein 1 (DRP1) and its receptors, including mitochondrial fission factor (MFF), mitochondrial fission one protein (FIS1). Increased mitochondrial fission is associated with oxidative stress, mitochondrial DNA (mtDNA) damage, mitochondrial membrane potential reduction and mitochondrial apoptosis activation.
Figure 3
Figure 3
Mitochondrial fusion is controlled by outer mitochondrial membrane (OMM)-localized mitofusin 2 (MFN2) and inner mitochondrial membrane (IMM)-localized optic atrophy 1 (OPA1). Increased mitochondrial fusion inhibits mitochondrial fission, sustains mitochondrial potential, promotes mitochondrial bioenergetics and suppresses mitochondrial apoptosis.
Figure 4
Figure 4
The most recognized mitophagy pathway in mammalian cells is mediated by PARKIN, a receptor-independent pathway. In addition to PARKIN-mediated mitophagy, receptor-dependent pathway for mitophagy induction includes Fun14 domain-containing protein 1 (FUNDC1). Mechanismically, the targeted mitochondria are engulfed by the pre-autophagosome, forming an autophagosome. Subsequently, microtubule-associated protein 1A/1B-light chain 3 (LC3) binds to phosphatidylethanolamine, generating the LC3-phosphatidylethanolamine conjugate (LC3II). Finally, the lysosome induces the proteolytic degradation of the autophagosomal proteins, nucleic acids, carbohydrates and lipids, which are recycled by the cell to restore homeostasis.
Figure 5
Figure 5
Mitochondrial death includes apoptosis and necroptosis. Apoptosis is regulated by outer mitochondrial membrane (OMM) permeabilization, mitochondrial membrane potential reduction, caspase-9 activation. Necroptosis is induced by the activation of RIPK3/MLKL pathway and the mPTP opening. Then, mitochondrial electron transport chain dysfunction and tricarboxylic acid cycle termination contribute to ATP exhaustion, cytoplasmic swelling, and membrane rupture.
Figure 6
Figure 6
Involvement of mitochondrial quality control in cardiac I/R injury. Under physiological conditions, healthy mitochondria support the functions of cardiomyocytes by ensuring optimal catabolic and anabolic metabolism and regulating the intracellular trafficking of Ca2+. Additionally, an intact mitochondrial network maintains inflammatory homeostasis and tissue integrity by preventing the activation of signal transduction cascades that lead to pro-inflammatory factor secretion and regulated cell death. Mitochondrial dysfunction is accompanied by metabolic derangements and alterations in the intracellular Ca2+ flux, and also promotes an inflammatory milieu and regulated cell death, which culminates in tissue loss.

References

    1. Heusch G. 25 years of remote ischemic conditioning: from laboratory curiosity to clinical outcome. Basic Res Cardiol. 2018;113:15. - PubMed
    1. Heusch G. Coronary microvascular obstruction: the new frontier in cardioprotection. Basic Res Cardiol. 2019;114:45. - PubMed
    1. Tai Y., Li L., Peng X., Zhu J., Mao X., Qin N. Mitochondrial uncoupler BAM15 inhibits artery constriction and potently activates AMPK in vascular smooth muscle cells. Acta Pharm Sin B. 2018;8:909–918. - PMC - PubMed
    1. Galluzzi L., Vitale I., Aaronson S.A., Abrams J.M., Adam D., Agostinis P. Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. Cell Death Differ. 2018;25:486–541. - PMC - PubMed
    1. Zhou H., Li N., Yuan Y., Jin Y.G., Guo H., Deng W. Activating transcription factor 3 in cardiovascular diseases: a potential therapeutic target. Basic Res Cardiol. 2018;113:37. - PubMed

LinkOut - more resources